Abstract BACKGROUND: Mesenchymal stem cells (MSCs) and/or biological scaffolds have been used to regenerate articular cartilage with variable success. In the present study we evaluated cartilage regeneration using a combination of bone marrow (BM)-MSCs, Hyalofast TM and/or native cartilage tissue following full thickness surgical cartilage defect in rabbits. METHODS: Full-thickness surgical ablation of the medial-tibial cartilage was performed in New Zealand white (NZW)
Introduction
Osteoarthritis (OA) is a complex disease which is characterized by the loss of structural and biomechanical functions of the extracellular matrix (ECM) [1, 2] . The ensuing changes in the ECM and the cellular components lead to gradual degeneration of the articular cartilage which is marked by cartilage softening, fibrillation and ulceration [1, 2] . OA is a progressive disease, where initial attempt in tissue remodeling and restoration of tissue homeostasis become soon overwhelmed by an imbalance between the anabolic and catabolic events, finally resulting in severe joint dysfunction and disability [3, 4] .
The function of the articular cartilage very much depends upon its morphological structure and bio-mechanical properties which in turn relies on the biochemical composition of the cartilage [5] . Articular cartilage is composed of chondrocytes embedded in the ECM which is rich in glycosaminoglycans (GAG), collagen fibrils and water [6] . The microarchitecture of the cartilage with its composition and arrangement of the fibrils, confers the biomechanical properties [6, 7] . These biomechanical effects additionally protect the underlying subchondral bone by facilitating shocks absorption and distribution of loads [8] . Involvement of the subchondral bone and its sclerosis is implicated in alteration of the biomechanical properties, in advanced stages of OA [9, 10] .
Injured or damaged articular cartilage has limited ability for self-repair or regeneration. Therefore, with time mild to moderate articular cartilage lesions evolve into full thickness lesions and becomes associated with clinical features of joint pain, swelling and joint dysfunction [11, 12] . Arthroscopic procedures for various conditions have identified multiple degrees of articular cartilage injuries in 63% of patients. Since articular cartilage has limited regeneration capacity, surgical procedures involving marrow stimulation [13] and chondrocyte implantations techniques [14] are being attempted which can help overcome OA by reparative/restorative methods respectively.
Marrow stimulation involved subchondral drilling which recruits stem cells to the site of the lesion and help cartilage repair. However, fibrocartilaginous transformation occurs eventually which fail to function like normal articular cartilage. Autologous chondrocyte implantation (ACI) has progressed through several generations and basically involved initial harvest of chondrocytes; their expansion in culture followed by injection of these cells to the sites of cartilage damage and covering them up either with the periosteal patch (First generation ACI) or with collagen membrane (Second generation ACI). The problems associated with the above two ACI techniques such as periosteal hypertrophy and cell leakage led to the use of matrix associated autologous chondrocyte transplantation (MACT) wherein the harvested chondrocytes were initially seeded onto the matrix, and then the matrix was transplanted to the lesion with fibrin glue [15, 16] . However, it was identified that there was not much difference in the clinical outcomes between ACI and marrow stimulation techniques.
Early diagnosis and treatment is imperative as partial to complete loss of the articular cartilage may lead to long term disability and difficulty in management. Furthermore, unlike other tissues cartilage has inherent poor regeneration capacity and therefore the management of OA is difficult and protracted. Current research therefore focuses more on the use of a matrix together with cells to support faster integration and cartilage regeneration. We in the present study used a combination of bone marrow mesenchymal stem cells (BM-MSCs), native cartilage tissue and a commercial bio-scaffold (Hyalofast TM ) to understand its efficiency in cartilage regeneration in vivo in New Zealand White rabbits with full thickness cartilage defect.
Materials and methods
The protocol for the use of both BM-MSCs and animals in the present study were approved by the Institutional Review Board (IACUC no. 113-157) and the Research Ethics Committee, King Abdulaziz University (KAU). Informed patient consent was obtained prior to derivation of human BM-MSCs. Animal experiments were performed in strict compliance with the ethical guidelines for humane treatment of animals as defined by KAU.
Derivation of human BM-MSCs
The human BM-MSCs were isolated according to our earlier established protocols [17] . Briefly, bone marrow aspirates collected in heparinized tubes (Becton Dickinson, New Jersey, USA) were directly plated (* 2 ml) into T175 cm 2 flasks (Greiner Bio-one) and cultured using Dulbecco's modified Eagles medium (Sigma, Missouri, USA) supplemented with 10% gamma irradiated fetal bovine serum (Sigma, Missouri, USA), 2 mM GlutaMax (Invitrogen, Life Technologies, California, USA), and antibiotic solution [penicillin (100 IU/ml; streptomycin (100 lg/ml); Sigma, Missouri, USA]. The monolayer of adherent cells was cultured and propagated under standard culture conditions of 37°C and 5% carbon dioxide (CO2) in atmospheric air. The derived cells were characterized for MSCs related stemness properties [17] .
Preparation of BM-MSCs
Early passages (P2-P4) of BM-MSCs in culture were trypsinized and pelleted. The supernatant was removed, and the cell pellet was resuspended in 10 ml of fresh culture medium and the cells counted. Aliquots of 1 9 10 6 cells in 1 ml of medium were prepared in 1.5 ml Eppendorf tubes. The cells were washed twice in phosphate buffer saline (PBS) between centrifugation steps and the final cell pellet was resuspended in 50 ll of PBS. The cells were maintained on ice until in vivo animal transplantation into the full thickness cartilage defect area together with cartilage pellet and/or bio-scaffold.
Preparation of cartilage pellet
Cartilage pellet was prepared from the cartilage scrapings obtained from the articular surface of the non-weight bearing area of the same knee joint in the rabbits at the time of surgery. The cartilage scrapings were placed in a petridish containing sterile PBS and finely minced with scissors to homogenize the tissue. The tissue homogenate was filtered using a cell strainer and the contents centrifuged at 1000 rpm for 5 min. The cartilage pellet thus obtained was then used for implantation into the defect area together with cells or bio-scaffold (Hyalofast TM ).
Commercial bioscaffold (Hyalofast TM )
Hyalofast TM is a biodegradable hyaluronic acid (HA) based scaffold used as a one-step surgical treatment for chondral and osteochondral defects. It can additionally act as a scaffold for MSCs to adhere, proliferate and promote differentiation into cartilage tissue. This nonwoven scaffold is versatile in nature and can be cut/modified to suit the topography of the joint lesions.
In vivo animal experiment
New Zealand White (NZW) male rabbits Eight mature NZW male rabbits, 9-12 months of age, weighing 3-4 kg were used in this study. They were housed under standard animal housing conditions of 27°C, with a 12-h dark/ light cycle. Humidity was maintained between 55 and 65%. All rabbits were fed with commercial rabbit feed along with fresh leafy vegetables and water ad libitum. The NZW rabbits were provided 1-week period of adaptation before use in experiments. Each animal was anaesthetized with intramuscular injection of 50 mg/kg ketamine and 50 mg/ kg xylazine, followed by 1% lignocaine at the operative site. Prophylactic antibiotic therapy (50 mg/kg cefazolin IM) was given 30 min prior to surgical intervention, and was followed by regular dose for 24 h. All experimental procedures were carried out at the 'Animal Surgical Research Laboratory', King Fahd Medical Research Center (KFMRC), King Abdulaziz University (KAU), Jeddah.
Experimental groups Initially, all the eight NZW rabbits were subjected to full thickness surgical ablation (1 9 1 cm) of the medial tibial cartilage, in both knee joints. The NZW rabbits were then divided into four separate groups based on the treatment regime as follows. Group I-untreated controls; Group II-rabbits treated with BM-MSCs (1 9 10 6 cells) and Hyalofast TM ; Group III-rabbits treated with BM-MSCs (1 9 10 6 cells) and homogenized cartilage pellet; and Group IV-rabbits treated with BM-MSCs (1 9 10 6 cells), Hyalofast TM and homogenized cartilage pellet ( Fig. 1) . All animals were then followed up until the end of the study period of 12 weeks and then sacrificed, for evaluation of gross tissue repair, histochemistry, bio-mechanical properties and magnetic resonance imaging (MRI) based scoring for cartilage regeneration.
Full thickness surgical ablation of medial tibial cartilage of the knee Briefly, following induction of general anesthesia, both knees were prepared with standard sterilization and draping for aseptic surgery. The rabbits were laid in dorsal recumbent position and each knee joint was opened separately through a medial parapatellar approach. Incision was taken down to the anteromedial joint capsule, with knee flexion to identify the anatomical landmarks. The extensor mechanism was dislocated laterally and the articular surface of the medial tibial cartilage of knee joints were exposed totally. A full thickness surgical ablation of the articular surface (measuring 1 9 1 cm in diameter and 2-3 mm in depth) was then performed using surgical drill and curettage. The surgical defect area was then implanted either with BM-MSCs (1 9 10 6 cells) and Hyalofast TM (Group II); BM-MSCs (1 9 10 6 cells) and homogenized cartilage pellet (Group III); and BM-MSCs (1 9 10 6 cells), Hyalofast TM and homogenized cartilage pellet (Group IV). The controls (Group I) did not receive any implantation. Following implantation of cells, cartilage pellet and scaffold, the extensor mechanism was relocated and the joint capsule was closed medially with 2-0 Vicryl. The skin was then closed by interrupted sutures using 3-0 Prolene and the region cleaned and dressed. Post-operatively, antibiotic therapy (50 mg/kg cefazolin IM) was given thrice daily for 48 h. Animals were allowed unrestricted activity and were closely monitored regularly for signs of wound infection and other complications.
Histological analysis
The tibial bone with the articular surface were dissected from all the NZW rabbits in different experimental groups and fixed in 10% buffered neutral formalin. The samples were then decalcified in 4% ethylenediaminetetraacetic acid (EDTA) and subsequently dehydrated using graded series of ethanol, before final embedding in paraffin blocks. Tissue sections were made in coronal plane including normal cartilage and surgical defect area. Separate tissue sections from each experimental group were then stained separately with hematoxylin and eosin (H&E) and toluidine blue using standard histological staining procedures. The histological images obtained using Olympus BX51 light microscope (Olympus Corporation, Tokyo, Japan) were examined by two independent certified pathologists (FA and MS). The International Cartilage Repair Society II (ICRS II) scoring system was used for histological evaluation of cartilage repair [18] . To understand whether the transplanted BM-MSCs survived and contributed to cartilage regeneration, immunohistochemistry for human nuclear antigen was performed. Briefly, the paraffin sections prepared from each group were deparaffinized and antigen retrieval done microwaving the tissue section in Tris/EDTA buffer at 98°C for 20 min. Following nonspecific blocking procedures the sections were incubated with monoclonal anti-human nuclear primary antibody (MAB 1281; Millipore), and stained with secondary antibody (Alexafluor 488) for 30 min and images obtained by using fluorescent microscope (EVOS TM FL Imaging System; ThermoFischer Scientific).
Magnetic resonance imaging
The knee joint of the sacrificed NZW rabbits from the four experimental groups were examined ex-vivo using a 9.4 T high field MRI scanner (BiospecAvance III 9.4 T/30, Bruker Biospin, Ettlingen, Germany). A circular polarized volume coil with receives and transmit configuration, was used. Morphological images of the cartilage were acquired using fat suppressed 3D fast low-angle shot (FLASH) and fat suppressed 2D rapid acquisition with relaxation-enhanced (RARE) sequences. T2 mapping of the cartilage was acquired using multi-slice multi-echo (MSME) spin echo based protocol.
Regenerated cartilage tissue was evaluated using 2-dimensional magnetic resonance observation of cartilage repair tissue (MOCART) scoring system [19] . Score 0 = no repair and score 100 = excellent repair. The evaluation criteria include nine variables and includes the degree of defect fill; the cartilage interface; cartilage surface; cartilage structure; the signal intensity; the constitution of subchondral lamina; the constitution of subchondral bone; possible adhesions and effusion.
Biomechanical assessment
The load bearing capacity of the regenerated cartilage following full-thickness surgical ablation of the tibial articular and treatment with BM-MSCs, cartilage pellet and Hyalofast TM in NZW rabbits was determined using LRX plus Materials tensile testing machine (AMETEK LLoyd Instruments, Ireland). Briefly, preload stress was calibrated to zero, and then an extension rate of 2 mm/min was applied to all samples and the data was acquired. The compression mode was applied to test the cartilage strength and a maximum load cell of 5 kilo Newton (kN) was applied for each sample. Auto-zero for load and extension was performed after each experiment to ensure accuracy. The results obtained were analyzed using the NEX-YGEN TM 4.0 software (AMETEK LLoyd Instruments, Ireland).
Results

Gross appearance
Control rabbits (Group I) showed poor regeneration ability and only contributed to minimal repair of the surgical defect. The experimental group that was transplanted with BM-MSCs and Hyalofast TM (Group II) showed partial tissue regeneration compared to the control. However, treatment with BM-MSCs and homogenized cartilage pellet (Group III); and BM-MSCs, Hyalofast TM and homogenized cartilage pellet (Group IV) demonstrated almost complete filling of the surgical defect area (Fig. 2) . ) also demonstrated marked cartilage loss, with absence of superficial and midzone layers as well as the tidemark. The normal arrangement of chondrocytes was lost, and more fibrous tissue was observed. Group III (BM-MSCs and cartilage pellet) and Group IV (BM-MSCs, cartilage pellet and Hyalofast TM ) showed marked to complete articular cartilage regeneration with intact superficial layer and orderly arrangement of chondrocytes in the mid and deep zones. Intact tidemark and calcified cartilage zone were evident (Fig. 3) .
Toluidine blue staining Group I and Group II demonstrated poor cartilage repair with very weak to absent staining of the matrix. Group III and Group IV showed intense hyaline matrix staining up to the superficial layer (Fig. 4) .
ICRS II scoring Evaluation of all parameters by two independent pathologists showed better cartilage regeneration profile in treatment groups compared to the control.
The mean percentage value of the overall assessment was 52.5% (Group I), 65.0% (Group II), 66% (Group III) and 75% (Group IV) respectively.
Immunohistochemistry Group I was negative for human anti-nuclear antibody and showed minimal background staining, while Group II, Group III and Group IV were positive (Fig. 5) (Fig. 5B, D) compared to the control.
MRI analysis
MRI of the knee joints of the treated rabbits showed varying grades of repair and filling of the defect. There was irregular destruction of the articular surfaces which correlated well with that of the histological findings. The MOCART score was 50 ± 5.66; 73.75 ± 3.75 and 76.25 ± 4.27 in Group II, Group III and Group IV respectively compared to the untreated control (Fig. 6 ).
Biomechanical properties
The load bearing capacity of the regenerated cartilage showed mild improvement in the treated groups, compared to the untreated control. Samples in Group I showed maximal load bearing up to 520 N and had sustained resistance to maximal load thrice before finally dropping down. Samples in Group II developed fractures around 160 N but showed resistance up to maximum of 170 N. Group III demonstrated load bearing capacity up to a maximum of 135 N and development of fine fissures. Group IV demonstrated the least resistance against the external load with maximal load bearing up to 34 N. Unlike other samples there was a complete drop in the resistance that was almost linear after reaching the breaking point (Fig. 7) .
Discussion
The present study highlights the effectiveness of a commercially available biological scaffold, when used with or without cells in cartilage regeneration. In the settings of a full thickness complete tibial articular cartilage ablation in rabbits, a combination of MSCs, cartilage pellet and Hyalofast TM demonstrated better cartilage regeneration compared to the use of Hyalofast TM alone or its combinations with MSCs or cartilage pellet.
The underlying pathology in OA is mainly articular cartilage damage and destruction, which by itself has inherent poor regeneration capacity. Current pharmacological therapies provide only symptomatic relief and advanced stages may require surgical intervention to help functional restoration. Recently stem cells and/or their derivatives are identified to help regenerate/restore damaged cartilage. Both autologous and allogeneic MSCs are used in various surgical procedures such as ACI and MACT to bring about cartilage regeneration [15, 16] . Direct intraarticular injections of MSCs derived from bone marrow, fat or other sources have demonstrated less synovial thickening, reduced osteophyte formation and delayed OA progression [20, 21] . However, in the absence of complete cure for OA, there is a continuous search for novel therapeutics.
The use of Hyalofast TM and BM-MSCs and/or cartilage pellet enhanced cartilage regeneration. The main composition of Hyalofast TM is hyaluronan (HA) which is one of the principal component of the articular cartilage matrix. Umbilical cord Wharton's jelly derived MSCs when cultured with two commercially available HA acid based hydrogels namely HyStem and HyStem-C resulted in increased production of collagen type II and differentiation [22] . Pro-inflammatory cytokine interleukin-1 beta (IL-1b) is associated with cartilage degradation via activation of the matrix metalloproteinases (MMPs), and HA demonstrated suppression of the MMPs that were stimulated with IL-1b and mechanical load, in an osteochondral explant tissue model derived from OA patients [23] . A multicenter randomized controlled clinical trial study has reported that intra-articular administration of HA together with culture expanded autologous BM-MSCs led to functional improvement of knee OA and also the quality of life [24] . Above studies indicate that HA has both chondro-inductive and chondro-protective effects, and Hyalofast TM , being mainly composed of HA probably facilitated BM-MSCs attachment and helped chondrocyte differentiation in the presence of native cartilage tissue.
Gross and microscopic analysis revealed better cartilage repair with Hyalofast TM and BM-MSCs and/or cartilage pellet as observed in the present study. Presence of intact superficial layer, organized arrangement of the chondrocytes, the tidemark and production of cartilage matrix indicated successful cartilage regeneration. Singh et al.
reported that direct intra-articular injection of BM-MSCs alone into the OA knee joint following anterior cruciate ligament transection in NZW rabbits helped cartilage regeneration [25] . Transplantation of human BM-MSCs that were earlier differentiated into chondrocytes in vitro together with a biphasic composite (platelet rich fibrin glue-hydroxyapatite) demonstrated superior hyaline-like cartilage formation at 8 weeks than with undifferentiated BM-MSCs [26] . Similarly, intra-articular injections of equine umbilical cord derived MSCs into NZW rabbits with medial meniscal release model of OA reported lesser cartilage fibrillation, reduction in MMPs, anti-catabolic and anti-inflammatory activities by acting upon the synovium [27] . Above studies indicate that xenogeneic MSCs can integrate with host tissue and contribute to cartilage tissue repair, which were similar to the results of our study. However, the same studies did not highlight the type and nature of the regenerated cartilage nor the biomechanical properties which are crucial for functional restoration of OA joint. In the present study too, we had used human BMMSCs for transplantation into NZW rabbits, and the In the present study MRI imaging and the MOCART score showed improvement in the experimental groups than the control. MOCART scoring system was specifically designed to evaluate the knee repair and serves as an index of tissue regeneration [19] . MRI imaging and its ability to understand the soft-tissue contrast enables direct visualization of the cartilage defect and/or their regeneration. Cartilage matrix that embeds the chondrocytes, especially comprising of collagen II and proteoglycans provide the tensile strength and contribute to the biomechanical properties. Importantly, HA forms a coat around the chondrocytes, and being negatively charged absorbs water molecules which in turn contributes to the resilience of the cartilage [28] . Biomechanical properties of cartilage are more reliably obtained using indentation testing and subsequent analysis of stress-relaxation curve as used in the present study. It has the unique advantage whereby load is tested without causing displacement of tissue; however, the orientation of the specimen is important to overcome the inherent anisotropic properties [29] . A recent prospective study where autologous bone marrow aspirate concentrate and Hyalofast TM were utilized to treat full thickness chondral defects in patients more than 45 years old reported effective functional restoration and decrease in pain. Therefore, it is evident that Hyalofast TM composed mainly of HA probably contributed as a right support for the stem cells to adhere and undergo cartilage differentiation efficiently.
Increase in the numbers of animals, immunostaining for collagen type and gene expression studies for cartilage specific genes would have added additional strength and more precise information to our study. Similarly, an interval and follow-up MRI after cells transplantation would have provided insights into direct in vivo cartilage regeneration status and functional outcome. The above limitations will be carefully addressed in our subsequent studies.
